Jenny Dawson

As Vice President of Business Insights and Performance Analytics at Verpora, Jenny leads a team of analysts, engineers, and consultants delivering a growing portfolio of advanced insight products for the pharmaceutical industry.

As product owner of Verpora’s flagship syndicated healthcare data solution, she brings deep expertise in transforming complex data into practical, strategic insight. Jenny guides the development of Verpora’s wider analytics offering, driving strategic line extensions, and delivery of scalable insight tools for high-cost drug optimisation.

Jenny developed her expertise at AstraZeneca, GlaxoSmithKline, SmithKline Beecham, before moving into senior roles at Roche where she built a UK data and analytics team and led a wide-ranging transformation of the analytics function. Her work included strategic forecasting, market research, and competitor analysis across oncology, haematology, neurology, and respiratory portfolios. She received personal recognition with the Roche Excellence Award in 2013 and contributed to Roche being named Best Business Intelligence Company of the Year in 2017.

As a Board Member of the British Healthcare Business Intelligence Association (BHBIA) for several years, Jenny has helped shape industry standards and ethical best practices in healthcare analytics.

Jenny brings a distinctive blend of strategic thinking, creative problem solving, and people-centred design to her work that bridges the gap between data, behaviour, and performance—helping clients uncover meaningful insight and apply it effectively.